We have observed the evolution of spatially fractionated radiotherapy (SFRT) primarily to manage metastatic cancer patients in the palliative care setting. Given recent advances in how SFRT can be delivered, can this therapeutic modality be optimized beyond the palliative care setting?
Palliative radiation therapy is underutilized across a variety of clinical settings, with reported disparities in palliative radiation therapy administration based on age, race, ethnicity, socioeconomic status and geography.
Bone radiotherapy (RT) is a foundation of the discipline and represents a significant portion of many practices. The standard protocols for palliative RT (8Gy x 1, 4Gy x 5, etc.) were pioneered almost 50 years ago, when systemic therapies were far less useful.
When patients are frail, older, have comorbidities or have a poor performance status, providing recommendations about the most appropriate radiotherapy regimen (or hospice) can be complicated. When is a long-course of radiotherapy most appropriate? Short-course palliative radiotherapy? SBRT?
This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a business fundamentals review and a radiopharmaceuticals overview.
There are many ongoing advances in clinical care in the context of palliative radiation therapy delivery, clinical decision-making on treatment options, and clinical workflows in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.
With this activity, ASTRO continues its series of challenging case panel sessions related to palliative radiotherapy for patients with advanced cancer.
Palliative radiotherapy (RT) is a foundation of the discipline and practically represents a significant portion of most practices. The standard protocols for palliative RT (8Gy x 1, 4Gy x 5, etc.) were pioneered almost 50 years ago, when systemic therapies were far less useful.
Facebook
X
LinkedIn
Forward
